BioSpace News Archive

Artemisinin Combination Therapy Market: Segmentation & Competitive Landscape

Artemisinin is a plant derivative isolated from Artemisia annua, or sweet wormwood, which is known to effectively and swiftly reduce the number of plasmodium parasites in the blood of malaria patients.

March 8, 2021
·
5 min read
Endodontic Files Market: High prevalence of dental disease and conditions is likely to be a key growth factor

Endodontic files are surgical instruments used by dentists while performing root canal treatment.

March 8, 2021
·
3 min read
ENT Surgery Microscopes Market: Increase in awareness about the advantages of ENT surgery microscopes to drive the growth of the market

Surgical microscope helps a surgeon to achieve optimal surgical outcome through high quality optical images. Ear, nose, and throat specialists use ENT microscopes to carry out routine surgical procedures.

March 8, 2021
·
4 min read
Ophthalmic Drug Delivery Devices Market: Rising Patient Preference for Targeted Ophthalmic Drug Delivery Devices is driving the Demand

Ophthalmic drug delivery devices refer to novel techniques introduced by key players in the market to deliver medications to the eye, especially to the posterior segment.

March 8, 2021
·
4 min read
RNA Transcriptome Profiling Tests Gaining Ground in Biotech and Pharma: Fact.MR

Increasing preference for precision medicine will remain a key factor propelling research and commercialization in the RNA transcriptome profiling test market in the near future.

March 8, 2021
·
6 min read
Veterinary Telehealth Market | Technological Advancements Observed across the Market may serve as a Profitable Growth Generator

The rising adoption of pets across the globe is extending the growth prospects of the global veterinary telehealth market.

March 8, 2021
·
4 min read
Deals

Calibre Scientific Acquires HUBERLAB, a Swiss Distributor of Life Science and Diagnostics Products, to Further Strengthen its Presence in the DACH Region

Calibre Scientific is pleased to announce the acquisition of HUBERLAB, a premier supplier of diversified products to laboratories in Switzerland.

March 8, 2021
·
1 min read
Policy

Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

Cara Therapeutics and Vifor Pharma announced that the U.S. Food and Drug Administration has accepted and granted Priority Review for the New Drug Application for KORSUVA™ solution for injection for the treatment of moderate-to-severe pruritus in hemodialysis patients.

March 8, 2021
·
7 min read
BioMidwest

Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization of mammalian, microbial biologics and gene therapy plasmid DNA, announces a licensing opportunity for pDNA manufacturing.

March 8, 2021
·
2 min read
Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform

Regenerative therapy to treat knee joint damages gets a boost with a breakthrough technology of growing ideal type of cartilage cells including chondroprogenitors and mesenchymal stem cells enriched with hyaluronic acid, reported by Dr Shojiro Katoh, President, Edogawa Hospital in “The KNEE” journal.

March 8, 2021
·
3 min read